BLM interaction with EZH2 regulates MDM2 expression and is a poor prognostic biomarker for prostate cancer.
Yong Ruan, Houqiang Xu, Xinqin Ji, Jiafu Zhao
Abstract
Yong Ruan, Houqiang Xu, Xinqin Ji, Jiafu Zhao
Abstract
observations. Our results demonstrated that the expression of P53 is affected by the binding of BLM and EZH2 to the MDM2 promoter region. This finding indicated that EZH2 regulates the expression of MDM2 at the transcriptional level by interacting with BLM.
OpenAlex reports 20 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
observations. Our results demonstrated that the expression of P53 is affected by the binding of BLM and EZH2 to the MDM2 promoter region. This finding indicated that EZH2 regulates the expression of MDM2 at the transcriptional level by interacting with BLM.
Key concepts: Gene knockdown, EZH2, Cancer research, Prostate cancer, Mdm2, In vivo, Biology, Cancer